tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Cash flow

Compare
124 Followers

Dermata Therapeutics Cash Flow

DRMA's free cash flow for Q3 2024 was $-3.42M. For the 2024 fiscal year, DRMA's free cash flow was decreased by $-11.16B and operating cash flow was $-3.42M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -11.16B$ -6.41M$ -8.83M$ -5.69M$ -4.03M
Investing Cash Flow
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 6.89B$ 7.61M$ 4.28M$ 15.96M$ 2.57M
End Cash Position
$ 3.16B$ 7.44M$ 6.24M$ 10.80M$ 530.40K
Free Cash Flow
$ -11.16B$ -6.41M$ -8.83M$ -5.69M$ -4.03M
Currency in USD

Dermata Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis